Published Date: 04 Mar 2023
UK: Pediatrics' first study published in JAMA Network Open concluded that pasteurization has no effect...
Read Full NewsSanofi's tolebrutinib fails to meet key trial endpoints for multiple sclerosis, delaying FDA review and raising questions about its future in treatment.
Neal K. Shah talked about how social robots could support emotional well-being in patients with neurologic conditions by reducing loneliness and promoting engagement in health-related activities.
Christopher Kenney, MD, FAAN, chief medical officer at Xenon Pharmaceuticals, reviews encouraging long-term data behind azetukalner, a first-in-class Kv7 channel opener, as a potential treatment for focal onset seizures.
This video explores skin pain as a key symptom of atopic dermatitis and reviews clinical trial data with JAK inhibitors.
Chronic Pain Associated With Significantly Reduced Ability to Relax Muscles
Global Data Suggest Increased Prevalence of Focal Segmental Glomerulosclerosis
Older Patients on Maintenance Dialysis Underrepresented in RCTs
1.
Added Plinabulin Boosts OS as Later-Line Treatment for EGFR Wild-Type NSCLC
2.
Video: Liver transplant for patients with advanced colorectal cancer
3.
No Survival Gain With Preoperative CRT Plus Perioperative Chemo for Gastric Cancer
4.
Weight loss and cancer; no brain tumor blood test; no cervical cancer after HPV vaccination.
5.
Combination treatment may help cut lifelong ibrutinib for chronic lymphocytic leukemia patients
1.
Breakthroughs in Oncology: Advances in Immunotherapy, Radiation & Precision Diagnostics
2.
Precision Oncology Advances: Neoantigen Therapies, TCR Strategies & Radiotherapy Innovations
3.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
4.
The Essential Guide to Understanding Fibrinogen and Its Role in Blood Clotting
5.
How to Prevent Tumor Lysis Syndrome in Cancer Patients
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
2.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
3.
Efficient Management of First line ALK-rearranged NSCLC - Part II
4.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation